Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of drug maker Supernus Pharmaceuticals, Inc. (SUPN) are rising more than 22% Wednesday morning on upbeat third quarter results. The company has also raised its full-year product sales outlook.


RTTNews | Nov 4, 2020 10:14AM EST

10:14 Wednesday, November 4, 2020 (RTTNews.com) - Shares of drug maker Supernus Pharmaceuticals, Inc. (SUPN) are rising more than 22% Wednesday morning on upbeat third quarter results. The company has also raised its full-year product sales outlook.

Net earnings in the third quarter were $39.997 million or $0.74 per share compared with $28.86 million or $0.54 per share in the same quarter a year ago due to 52% year-over-year growth in product sales.

Total revenues were $155.14 million compared with $100.03 million in the same quarter a year ago.

Supernus has raised its full-year sales outlook to the range of $500 million to $525 million from $460 million- $500 million provided earlier.

Supernus shares are currently at $22.15 and have been trading in the range of $13.12- $29.36 in the last one year.

Read the original article on RTTNews ( https://www.rttnews.com/3142813/stock-alert-supernus-pharmaceuticals-jumps-22-on-quarterly-results-sales-view.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC